Clinical Trial Update: A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC) [Phase 2]

View source ↗

Summary

Phase 2 double-masked, placebo-controlled trial from Aldeyra Therapeutics evaluated reproxalap for mild atopic asthma induced by bronchial allergen challenge. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Asthma

Drugs mentioned

• Reproxalap (reproxalap)

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Atopic Asthma | Phase 2 | Status: COMPLETED | Results posted: 2025-02-17